Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
131.60    -4.30 (-3.16%)
Bid:
131.30
Ask:
131.50
Spread: 0.20 (0.152%)
Market Cap: £332.80m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Director/PDMR Shareholding

4 Apr 2006 10:32

Marshalls PLC04 April 2006 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS On 31 March 2006 Marshalls plc (the "Company") was notified that, on that date,Marshalls EBT Limited, the Trustee of the Marshalls plc 2005 Employee BenefitTrust, purchased 175,000 ordinary shares of 25 pence each in the Company at aprice of 345 pence per share on behalf of Directors and Senior Executives whoare participating in the Marshalls plc 2005 Long Term Incentive Plan(the "LTIP"). Under the rules of the LTIP Directors and Senior Executives undertake to use apercentage of their bonus to purchase shares in the Company ("InvestmentShares") and, in return, are granted a Matching Award of shares. Directors and Senior Executives have irrevocably committed to use a fixed sum ofmoney payable from their 2005 bonus to purchase Investment Shares and theCompany has granted them Matching Awards over such number of shares that equalstwo times the number of shares that the Directors and Senior Executives couldhave bought had the investment of his or her bonus been made on a pre-tax basis. To be eligible to receive the Matching Award, the Directors and SeniorExecutives must leave their Investment Shares in the Trust and remain inemployment for a period of three years from the date of grant of the MatchingAward. The actual number of shares transferred to a Director or SeniorExecutive on the vesting of the Matching Award will depend on the extent towhich a corporate performance target (which relates to growth in the Company'searnings per share) is satisfied over the three-year vesting period. Fulldetails of the LTIP are provided in the Directors' Remuneration Report inthe Marshalls plc 2004 Annual Report. The following Directors and Senior Executives (being persons dischargingmanagerial responsibilities ("PDMRs")) acquired interests in shares under theLTIP as follows: Number of Total beneficial Number of shares Investment Shares shareholding following granted under purchased this announcement Matching AwardDirectorGraham Holden 31,424 245,530 106,521Ian Burrell 16,231 42,947 55,018David Sarti 13,912 30,341 47,158 PDMRElizabeth Blease 870 870 2,947Christopher Harrop 870 870 2,947Kevin Hull 870 2,052 2,947Michael Wignall 2,609 2,609 8,843 The Directors of Marshalls EBT Limited are David Graham Holden and Ian DavidBurrell who are Directors of the Company. David Graham Holden, Ian David Burrell and David Neil Sarti as Directors andElizabeth Blease, Christopher Harrop, Kevin Hull and Michael Wignall as PDMRsare amongst the potential beneficiaries of the Trust and are regarded forCompanies Act purposes as being interested in all the Marshalls plc ordinaryshares held by the Trust, although the shares held by the Trust are also heldfor the benefit of other employees of the Company. Despite the technicalinterest in the shares, the Directors and PDMRs will only be entitled to receivethat number of shares to which they would be entitled on exercise of an award oroption which has been granted to them. Enquiries: Elizabeth Blease, Company Secretary, Marshalls plc, 01484 438900 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 202612:17 pmRNSHolding(s) in Company
22nd May 20264:01 pmRNSDirector/PDMR Shareholding
22nd May 20263:58 pmRNSDirector/PDMR Shareholding
15th May 202611:04 amRNSDirector/PDMR Shareholding
15th May 202611:03 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
13th May 20263:08 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Trading Update
15th Apr 202612:17 pmRNSDirector/PDMR Shareholding
15th Apr 202612:15 pmRNSDirector/PDMR Shareholding
17th Mar 20263:01 pmRNSDirector/PDMR Shareholding
17th Mar 20262:59 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSFinal Results
16th Mar 20267:00 amRNSFinal Results
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RNotice of Engage Investor Presentation
13th Feb 20263:21 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
19th Jan 20267:01 amRNSTrading Statement
19th Jan 20267:00 amRNSDirectorate change
9th Jan 202612:40 pmRNSDirector/PDMR Shareholding
9th Jan 202612:38 pmRNSDirector/PDMR Shareholding
6th Jan 20269:36 amRNSNotice of Trading Update
9th Dec 20253:21 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSBoard changes
12th Nov 20257:00 amRNSTrading Update
10th Nov 202510:30 amRNSDirector/PDMR Shareholding
10th Nov 202510:29 amRNSDirector/PDMR Shareholding
10th Nov 202510:27 amRNSDirector/PDMR Shareholding
30th Oct 20259:01 amRNSNotice of Trading Update
9th Oct 202512:45 pmRNSDirector/PDMR Shareholding
9th Oct 202512:44 pmRNSDirector/PDMR Shareholding
9th Oct 202512:42 pmRNSDirector/PDMR Shareholding
10th Sep 202512:06 pmRNSDirector/PDMR Shareholding
10th Sep 202512:05 pmRNSDirector/PDMR Shareholding
10th Sep 202512:04 pmRNSDirector/PDMR Shareholding
12th Aug 20259:28 amRNSDirector/PDMR Shareholding
11th Aug 20251:57 pmRNSDirector/PDMR Shareholding
11th Aug 20257:00 amRNSHalf year results
7th Aug 20257:00 amRNSDirectorate Change
28th Jul 202512:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.